... earnings accretion, and accelerated cash ... BDSI common stock will cease to be traded on the Nasdaq Global Select Market. ... Head of Investor Relations adasalla ...
People also ask
Who bought BDSI?
What does Collegium Pharmaceutical do?
BioDelivery Sciences International, Inc. operates as a specialty pharmaceutical company in the United States. Its patented drug delivery technologies ...
CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS. This presentation and any statements of employees, representatives, and partners of BioDelivery Sciences ...
Missing: relations | Show results with:relations
The Investor Relations website contains information about Biodesix's business for stockholders, potential investors, and financial analysts.
Feb 14, 2022 · ... BDSI's common stock. Following ... Investors” section of BDSI's website at ir.bdsi.com. ... Head of Investor Relations and Corporate Communications
People also search for
... Investors" section of our website, available at www.bdsi.com. Investors are encouraged to review the Investors ... annual report on Form 10-K for the year ended ...
Feb 14, 2022 · ... BDSI's common stock. Following ... Investors” section of BDSI's website at ir.bdsi.com. ... Head of Investor Relations and Corporate Communications.
Jan 13, 2006 · MORRISVILLE, N.C.--(BUSINESS WIRE)--Jan. 13, 2006--BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has retained The Investor ...
Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Biodelivery Sciences International Inc (BDSI) using our online tools.
Missing: investor | Show results with:investor
Biodelivery Sciences International (BDSI) stock investors activity – investors allocate an average of 0.00% to BDSI, based on 591065 active investor ...
Missing: relations | Show results with:relations